NM

Nadav Mizrahi

VP R&D

Sensible Medical Innovations

Therapeutic Areas

Sensible Medical Innovations Pipeline

DrugIndicationPhase
ReDS™ SystemPulmonary congestion monitoring in heart failure and other fluid‑related conditionsCommercial